A_DT
novel_JJ
Ets-related_JJ
transcription_NN
factor_NN
,_,
Elf-1_NN
,_,
binds_VBZ
to_TO
human_JJ
immunodeficiency_NN
virus_NN
type_NN
2_CD
regulatory_JJ
elements_NNS
that_WDT
are_VBP
required_VBN
for_IN
inducible_JJ
trans_JJ
activation_NN
in_IN
T_NN
cells_NNS
._.

Human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
-LRB-_-LRB-
HIV-1_NN
-RRB-_-RRB-
and_CC
HIV-2_NN
are_VBP
structurally_RB
related_JJ
retroviruses_NNS
which_WDT
both_DT
cause_VBP
AIDS_NN
in_IN
humans_NNS
._.

Although_IN
both_DT
viruses_NNS
establish_VBP
latency_NN
in_IN
quiescent_JJ
human-peripheral-blood_JJ
T_NN
cells_NNS
,_,
the_DT
asymptomatic_JJ
phase_NN
of_IN
HIV-2_NN
infection_NN
may_MD
be_VB
more_RBR
prolonged_JJ
than_IN
that_DT
of_IN
HIV-1_NN
._.

The_DT
latent_JJ
phases_NNS
of_IN
both_CC
HIV-1_NN
and_CC
HIV-2_NN
infection_NN
have_VBP
been_VBN
shown_VBN
to_TO
be_VB
disrupted_VBN
by_IN
T-cell_NN
activation_NN
,_,
a_DT
process_NN
that_WDT
requires_VBZ
host_NN
cell_NN
transcription_NN
factors_NNS
._.

In_IN
the_DT
case_NN
of_IN
HIV-1_NN
,_,
the_DT
transcription_NN
factor_NN
NF-kappa_NN
B_NN
is_VBZ
sufficient_JJ
for_IN
inducible_JJ
transcriptional_JJ
activation_NN
._.

In_IN
contrast_NN
,_,
factors_NNS
in_IN
addition_NN
to_TO
NF-kappa_NN
B_NN
are_VBP
required_VBN
to_TO
activate_VB
HIV-2_NN
transcription_NN
in_IN
infected_JJ
T_NN
cells_NNS
._.

In_IN
this_DT
report_NN
,_,
we_PRP
demonstrate_VBP
that_IN
a_DT
novel_JJ
Ets-related_JJ
transcription_NN
factor_NN
,_,
Elf-1_NN
,_,
binds_VBZ
specifically_RB
to_TO
two_CD
purine-rich_JJ
motifs_NNS
in_IN
the_DT
HIV-2_NN
enhancer_NN
._.

Mutagenesis_NN
experiments_NNS
demonstrated_VBD
that_IN
these_DT
Elf-1_NN
binding_NN
sites_NNS
are_VBP
required_VBN
for_IN
induction_NN
of_IN
HIV-2_NN
transcription_NN
following_VBG
T-cell-receptor-mediated_JJ
T-cell_NN
activation_NN
._.

Moreover_RB
,_,
Elf-1_NN
is_VBZ
the_DT
only_JJ
factor_NN
present_JJ
in_IN
activated_VBN
T-cell_NN
nuclear_JJ
extracts_NNS
that_WDT
binds_VBZ
to_TO
these_DT
sites_NNS
in_IN
electrophoretic_JJ
mobility_NN
shift_NN
assays_NNS
._.

Thus_RB
,_,
Elf-1_NN
is_VBZ
a_DT
novel_JJ
transcription_NN
factor_NN
that_WDT
appears_VBZ
to_TO
be_VB
required_VBN
for_IN
the_DT
T-cell-receptor-mediated_JJ
trans_JJ
activation_NN
of_IN
HIV-2_NN
gene_NN
expression_NN
._.

These_DT
results_NNS
may_MD
explain_VB
differences_NNS
in_IN
the_DT
clinical_JJ
spectra_NNS
of_IN
diseases_NNS
caused_VBN
by_IN
HIV-1_NN
and_CC
HIV-2_NN
and_CC
may_MD
also_RB
have_VB
implications_NNS
for_IN
the_DT
design_NN
of_IN
therapeutic_JJ
approaches_NNS
to_TO
HIV-2_NN
infection_NN
._.

